Article

Key Stakeholders Needed in the Development of Outpatient Naloxone Policies

Conference|PAINWeek Conference

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses key stakeholders involved in developing and implementing outpatient naloxone policies.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses key stakeholders involved in developing and implementing outpatient naloxone policies.

Related Videos
Related Content
Research Shows Guillain-Barré Syndrome Remains Rare Among Older Adults After RSV Vaccination
December 21st 2024

Research Shows Guillain-Barré Syndrome Remains Rare Among Older Adults After RSV Vaccination

Aislinn Antrim, Assistant Managing Editor
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
HIV test strip | Image Credit: © Mulin - stock.adobe.com
December 21st 2024

FDA Approves Premarket Approval Application for OraQuick HIV Self-Test, Expanding Access to Adolescents

Alexandra Gerlach, Associate Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

FDA Approval, Weight Loss, Pediatrics | Image Credit: Aquir | stock.adobe.com
December 20th 2024

FDA Approves Expanded Indication for Setmelanotide to Include Patients 2 and Older

Ashley Gallagher, Associate Editor
Varicella zoster or chickenpox virus, ai illustration. A herpes virus which cause chickenpox and shingles - Image credit: Cristina | stock.adobe.com
December 20th 2024

Study: Fatal Disseminated Herpes Zoster in Immunocompetent Individuals

Kennedy Ferruggia, Assistant Editor